Amy was Senior Vice President, R&D Strategy and Business Management at Sage Therapeutics, and Vice President Regulatory Affairs at Sunovion Pharmaceuticals. Amy Schacterle joined Acumen Pharmaceuticals in 2024.
Amy Schacterle is currently
Create your alert
to follow the career of Amy Schacterle.
Amy Schacterle has a Bachelor in Biomedical Engineering from Rensselaer Polytechnic Institute and a PhD in Biomedical Engineering from University of Virginia.
They have also studied at Rensselaer Polytechnic Institute :
Find more alumni from Rensselaer Polytechnic Institute
They have also studied at University of Virginia :
Find more alumni from University of Virginia
Do you need to know more about Amy Schacterle? More results.
Report an error
Update the org chart details of Amy Schacterle.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.